CNBC Squawk Box

On Monday, Pfizer CEO Albert Bourla said a vaccine that targets the super-contagious and pernicious Omicron variant of COVID-19 will be ready in March, and the company’s already begun manufacturing the doses. “This vaccine will be ready in March,” Bourla told CNBC’s “Squawk Box.” “We [are] already starting manufacturing some of these quantities at risk.” Bourla said the vaccine will also target the other variants that are circulating. He said […]